What drove 2228.HK stock’s move today?

The move was driven by active volume **96,563,875.00**, profit-taking from a recent rally and overbought technicals (RSI **76.82**). Short-term momentum and sector news on AI drug discovery amplified trading.

What are Meyka AI’s forecast numbers for 2228.HK stock?

Meyka AI's forecast model projects **HK$16.04** (1 month), **HK$11.67** (quarter), and **HK$10.46** (1 year). These are model projections and not guarantees.

How does valuation look for 2228.HK stock?

Headline PE is **12.96** with elevated price-to-sales and price-to-book multiples versus some peers. The company trades as a growth AI stocks play, requiring execution to justify current pricing.

What are the main risks for investors in 2228.HK stock?

Key risks are stretched receivables (~268 days), negative free cash flow per share, dependency on biotech funding cycles, and execution risk in commercialising AI platforms.

HK Stocks

HK$12.63 close on 26 Jan 2026: 2228.HK XtalPi HKSE AI pipeline, valuation gap

ByHuzaifa Zahoor January 26, 2026

The 2228.HK stock closed at HK$12.63 on 26 Jan 2026 after a session that tested the recent rally. Volume finished at 96,563,875.00 shares, above the 50-day average, signalling active trading in XtalPi. Investors are weighing strong AI drug-discovery revenue growth against stretched multiples and a high RSI. This update ties company metrics, sector context, and model forecasts to explain where XtalPi (2228.HK) sits on the Hong Kong Stock Exchange (HKSE) for AI stocks.